If you have high blood pressure and are experiencing insomnia, its important to talk to your doctor
Semaglutide still the GLP-1 heavyweight If Novo Nordisks semaglutide were counted as a single drug, it would be second bestselling drug of 2023, with total sales of $19.93 billion compared to Keytrudas (pembrolizumab) $25.01 billion
GLP-1 drugs like Ozempic and Mounjaro have helped many people lose weight and manage type 2 diabetes, but a big question remains: what happens when people stop using them
Coaches are already making it happen, and you can too
One thing worth knowing: Cary, the suburb between Raleigh and Durham, has a local joke that it stands for "Containment Area for Relocated Yankees." It's said with affection (mostly), but it captures the real cultural dynamic between Triangle natives and newcomers that shapes everything here, including healthcare expectations